| 臺大學術典藏 |
2022-09-15T03:45:33Z |
An integrative approach for pediatric auditory neuropathy spectrum disorders: revisiting etiologies and exploring the prognostic utility of auditory steady-state response
|
Lin P.-H.; Hsu C.-J.; Lin Y.-H.; Lin Y.-H.; Yang S.-Y.; Yang T.-H.; Chen P.-L.; Wu C.-C.; TIEN-CHEN LIU |
| 臺大學術典藏 |
2022-09-15T03:45:33Z |
Tinnitus and tinnitus disorder: Theoretical and operational definitions (an international multidisciplinary proposal)
|
Lin P.-H.; Hsu C.-J.; Lin Y.-H.; Lin Y.-H.; Yang S.-Y.; Yang T.-H.; Chen P.-L.; Wu C.-C.; TIEN-CHEN LIU |
| 臺大學術典藏 |
2022-09-15T03:45:32Z |
Toward the pathogenicity of the slc26a4 p.C565y variant using a genetically driven mouse model
|
Yang T.-H.; Huang H.-M.; Hsu W.-C.; Tsao P.-N.; TIEN-CHEN LIU; Hsu C.-J.; Huang L.-M.; Wu C.-S.; Weng S.-M.; Lu C.-Y.; Wu C.-C. |
| 臺大學術典藏 |
2022-09-15T03:45:32Z |
Within-Subject Analysis of Auditory Brain Stem Responses in Adults With Unilateral Tinnitus
|
Hu C.-J.; Lu Y.-C.; Yang T.-H.; Chan Y.-H.; Tsai C.-Y.; Yu I.-S.; Lin S.-W.; TIEN-CHEN LIU; Cheng Y.-F.; Wu C.-C.; Hsu C.-J. |
| 臺大學術典藏 |
2022-09-15T03:45:31Z |
Long-term hearing progression of Ménière’s disease
|
Hu C.-J.; Lu Y.-C.; Tsai C.-Y.; Chan Y.-H.; Lin P.-H.; Lee Y.-S.; Yu I.-S.; Lin S.-W.; TIEN-CHEN LIU; Hsu C.-J.; Yang T.-H.; Cheng Y.-F.; Wu C.-C. |
| 臺大學術典藏 |
2022-09-15T03:45:30Z |
Hearing Features and Cochlear Implantation Outcomes in Patients With Pathogenic MYO15A Variants: a Multicenter Observational Study
|
Lo T.-H.; Lin P.-H.; Hsu W.-C.; Tsao P.-N.; TIEN-CHEN LIU; Yang T.-H.; Hsu C.-J.; Huang L.-M.; Lu C.-Y.; Wu C.-C. |
| 臺大學術典藏 |
2022-09-15T03:45:29Z |
Comprehensive Etiologic Analyses in Pediatric Cochlear Implantees and the Clinical Implications
|
Lin P.-H.; Wu H.-P.; Wu C.-M.; Chiang Y.-T.; Hsu J.S.; Tsai C.-Y.; Wang H.; Tseng L.-H.; Chen P.-Y.; Yang T.-H.; Hsu C.-J.; Chen P.-L.; Wu C.-C.; TIEN-CHEN LIU |
| 臺大學術典藏 |
2022-09-15T03:45:29Z |
Cochlear Implantation Outcomes in Patients with Auditory Neuropathy Spectrum Disorder of Genetic and Non-Genetic Etiologies: A Multicenter Study
|
Chen P.-Y.; Tsai C.-Y.; Wu J.-L.; Li Y.-L.; Wu C.-M.; Chen K.-C.; Hwang C.-F.; Wu H.-P.; Lin H.-C.; Cheng Y.-F.; Lo M.-Y.; TIEN-CHEN LIU; Yang T.-H.; Chen P.-L.; Hsu C.-J.; Wu C.-C. |
| 臺大學術典藏 |
2022-09-14T01:29:28Z |
Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan
|
Yang T.-H.; Fang Y.-J.; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-09-07T07:41:22Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; HAN-MO CHIU; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:50:56Z |
Endoscopic hemostasis of a bleeding marginal ulcer: Hemoclipping or dual therapy with epinephrine injection and heater probe thermocoagulation
|
YI-CHIA LEE; Wang H.-P.; Yang C.-S.; Yang T.-H.; Chen J.-H.; Lin C.-C.; Tsai C.-Y.; Chang L.-Y.; Huang S.-P.; Wu M.-S.; Lin J.-T. |
| 臺大學術典藏 |
2022-09-07T06:50:06Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:50:01Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-09-07T06:49:54Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; YI-CHIA LEE; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:53Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:46Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; YI-CHIA LEE; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:45Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; YI-CHIA LEE; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:39Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; Fang Y.-J.; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; YI-CHIA LEE; Liou, J.-M.; Wu, M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-07T06:49:33Z |
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis
|
Chen M.-J.; Bair M.-J.; Chen P.-Y.; Lee J.-Y.; Yang T.-H.; Fang Y.-J.; Chen C.-C.; Chang A.-T.; Hsiao W.-D.; Yu J.-J.; Kuo C.-C.; Chiu M.-C.; Lin K.-P.; Tsai M.-H.; Hsu Y.-C.; Chou C.-K.; Chen C.-Y.; Lin J.-T.; YI-CHIA LEE; Wu M.-S.; Liou J.-M.; forthe Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-09-06T08:57:11Z |
Serum pepsinogen I, II, and the ratio of pepsinogen I / pepsinogen II in the intestinal metaplasia of the stomach
|
Chang S.-Y.; MING-SHIANG WU; Shun C.-T.; Wang H.-H.; Yang T.-H.; Liu C.-Y.; Lin J.- T. |
| 臺大學術典藏 |
2022-09-06T08:56:52Z |
Synchronous triple cancers at middle and lower esophagus and stomach with different histological features and genetic alterations
|
Chang Y.-T.; Tsai C.-I.; Yang T.-H.; Shih C.-W.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T08:56:50Z |
Endoscopic hemostasis of a bleeding marginal ulcer: Hemoclipping or dual therapy with epinephrine injection and heater probe thermocoagulation
|
Lee Y.-C.; Wang H.-P.; Yang C.-S.; Yang T.-H.; Chen J.-H.; Lin C.-C.; Tsai C.-Y.; Chang L.-Y.; Huang S.-P.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2022-09-06T07:43:26Z |
Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria
|
Hsu Y.-C.; Liou J.-M.; Liao S.-C.; Yang T.-H.; Wu H.-T.; Hsu W.-L.; Lin H.-J.; Wang H.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2022-09-06T07:43:20Z |
Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: Is therapeutic response predicted by Rome III subgroups?
|
Hsu Y.-C.; Liou J.-M.; Yang T.-H.; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; Wang H.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2022-09-06T07:43:14Z |
Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?
|
Hsu Y.-C.; Yang T.-H.; Liou J.-M.; Hsu W.-L.; Lin H.-J.; Wu H.-T.; Lin J.-T.; Wang H.-P.; MING-SHIANG WU |
